0001214659-14-005573.txt : 20140804
0001214659-14-005573.hdr.sgml : 20140804
20140804170010
ACCESSION NUMBER: 0001214659-14-005573
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140723
FILED AS OF DATE: 20140804
DATE AS OF CHANGE: 20140804
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG CAPITAL PARTNERS LP
CENTRAL INDEX KEY: 0001191935
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 141013651
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001232621
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 141013652
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-200-3830
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG KEVIN C
CENTRAL INDEX KEY: 0001178579
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 141013653
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
3
1
marketforms-25536.xml
PRIMARY DOCUMENT
X0206
3
2014-07-23
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001178579
TANG KEVIN C
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
false
false
true
false
0001232621
TANG CAPITAL MANAGEMENT LLC
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
false
false
true
false
0001191935
TANG CAPITAL PARTNERS LP
4747 EXECUTIVE DRIVE
SUITE 510
SAN DIEGO
CA
92121
false
false
true
false
Common Stock
1699067
I
By LP
Series C-1(2) Convertible Preferred Stock
2012-01-19
Common Stock
6167289
I
By LP
The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP. Mr. Tang disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest therein.
The Series C-1(2) Convertible Preferred Stock (the "Series C Stock") can only be converted into Common Stock to the extent that, after such conversion, the holder would beneficially own no more than 9.999% of the issuer's Common Stock. As such, none of the Series C Stock reported herein is currently convertible into the issuer's Common Stock.
The Series C Stock has no expiration date.
Each share of Series C Stock is convertible into the issuer's Common Stock at a rate of 1,724 shares of Common Stock for each share of Series C Stock tendered for conversion.
/s/ Kevin C. Tang
2014-08-04
/s/ Kevin C. Tang, Managing Member
2014-08-04
/s/ Kevin C. Tang, Managing Member of Tang Capital Management LLC, General Partner
2014-08-04